DSC2 Antibody

What is DSC2 and why is it important in cellular research?

Desmocollin-2 (DSC2) is a 100-110 kDa transmembrane glycoprotein belonging to the cadherin family of calcium-dependent adhesion molecules. It serves as a principal component of desmosomes, which form adhesive contacts between epithelial cells . Human DSC2 is synthesized as a 901 amino acid precursor with a 108 aa propeptide and a mature region consisting of a 559 aa extracellular domain (containing five cadherin-like domains), a 21 aa transmembrane segment, and a 186 aa cytoplasmic region .

DSC2 is particularly important in research because, unlike other desmocollins (DSC1 and DSC3), it is expressed not only in stratified epithelia but also in simple epithelia lining the gastrointestinal tract, liver, and kidney . Additionally, it is expressed in the myocardium, making it relevant for both epithelial and cardiac research . Its role in maintaining tissue integrity through desmosome formation makes it a critical target for studies on cell adhesion, tissue architecture, and related pathologies.

What types of DSC2 antibodies are available for research applications?

Researchers can access several types of DSC2 antibodies optimized for different experimental approaches:

• Polyclonal antibodies: These recognize multiple epitopes on DSC2 and are available from various hosts including rabbit and sheep .

• Target-specific antibodies: Some antibodies specifically target the extracellular domain of DSC2, allowing for studies of the protein's external interactions .

• Species-specific antibodies: Human-specific and mouse-specific DSC2 antibodies are available, with human DSC2 antibodies recognizing regions such as Arg136-Arg684 , and mouse DSC2 antibodies targeting regions like Arg136-Pro694 .

The selection of an appropriate antibody depends on the experimental design, target species, and specific application requirements. For cross-species studies, it's important to note that human DSC2 shares 74%-79% amino acid sequence identity with bovine, mouse, and rat DSC2 .

What are the validated applications for DSC2 antibodies?

DSC2 antibodies have been validated for multiple research applications:

• Immunofluorescence labeling (typically at 1:100 dilution)

• Immunohistochemistry (IHC)

• Western blot analysis for protein detection and quantification

• Immunoprecipitation for protein-protein interaction studies

• Immunocytochemistry (ICC) for cellular localization studies

When planning experiments, researchers should note that optimal dilutions should be determined empirically for each laboratory's specific conditions and applications . Validation on known positive and negative controls is essential for ensuring antibody specificity to DSC2 .

How should DSC2 antibodies be stored and handled to maintain activity?

Proper storage and handling of DSC2 antibodies is critical for maintaining their efficacy:

• Use a manual defrost freezer and avoid repeated freeze-thaw cycles to prevent protein degradation .

• Long-term storage: 12 months from date of receipt at -20 to -70°C as supplied .

• Medium-term storage: After reconstitution, store for up to 1 month at 2 to 8°C under sterile conditions .

• Extended storage after reconstitution: Up to 6 months at -20 to -70°C under sterile conditions .

Some antibodies may be supplied in storage buffers containing preservatives like sodium azide (0.1%) , which should be considered when designing experiments as it may affect certain enzymatic assays or cell-based studies.

How can I validate the specificity of a DSC2 antibody for my experimental system?

Validating DSC2 antibody specificity requires a multi-faceted approach:

• Tissue expression profile comparison: Compare your antibody staining pattern with known DSC2 expression patterns. DSC2 is expressed in epithelia, myocardium, and lymph nodes . It is found in both basal and suprabasal layers of stratified epithelia and in simple epithelia lining the gastrointestinal tract, liver, and kidney .

• Positive and negative control tissues: Test your antibody on tissues known to express DSC2 positively and negatively . For instance, mouse embryo (15 d.p.c.) sections show specific DSC2 staining localized to the plasma membranes of epithelial cells when properly validated .

• Subcellular localization verification: Confirm that staining is primarily localized to the plasma membrane and at cell junctions/desmosomes, consistent with DSC2's known cellular distribution .

• Knockdown/knockout controls: When possible, use DSC2 knockdown or knockout samples as negative controls to confirm antibody specificity.

• Multiple detection methods: Validate specificity using more than one method (e.g., Western blot and immunofluorescence) to ensure consistent results across different applications.

• Pre-absorption tests: Pre-incubate the antibody with its immunizing peptide to confirm that this eliminates specific staining.

What are the critical considerations when using DSC2 antibodies to study desmosomal disorders?

When investigating desmosomal disorders with DSC2 antibodies, several critical factors must be considered:

• Mutation-specific effects: Various DSC2 mutations affect different protein domains and can influence antibody recognition. For example, variants affecting the prodomain of DSC2 can impact protein transport to the plasma membrane and potentially alter antibody accessibility to epitopes .

• Domain-specific antibodies: Select antibodies targeting specific domains (e.g., extracellular domain) depending on the disorder being studied. For ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy), mutations in the desmosomal gene desmocollin-2 are associated with the disease, and domain-specific antibodies can help characterize the molecular pathology .

• Splice variant consideration: DSC2 exists in long and short splice forms that differ in their cytoplasmic regions . Ensure your antibody recognizes the relevant splice variant for your study, or use antibodies that detect both forms if comparing their relative expression.

• Disease-specific expression changes: In certain pathologies, DSC2 expression patterns change. For example, during colon carcinogenesis, DSC2 is downregulated while DSC1 and DSC3 are upregulated . Design experiments to account for these potential expression shifts.

• Co-staining approaches: Consider co-staining with other desmosomal proteins (e.g., Desmoglein-2) to evaluate complex formation and interaction abnormalities, as DSC2 forms both homophilic interactions and heterophilic interactions with Desmoglein-2 .

How can I differentiate between detection of mature DSC2 and its precursor forms in experimental systems?

Differentiating between mature DSC2 and its precursor forms requires careful experimental design:

• Molecular weight discrimination: The precursor form of human DSC2 includes a 108 aa propeptide segment that is cleaved during maturation . On Western blots, this should yield detectable size differences, with the mature protein appearing at approximately 100-110 kDa and the precursor at a slightly higher molecular weight.

• Domain-specific antibodies: Use antibodies that specifically target either:

  • The prodomain (to detect only the precursor form)

  • Epitopes present only in the mature protein (after prodomain cleavage)

  • The mature extracellular domain (present in both forms but may show differential accessibility)

• Subcellular localization studies: The prodomain is critical for intracellular transport of DSC2 to the plasma membrane . Immunofluorescence can help distinguish between mature DSC2 (predominantly at the plasma membrane and desmosomes) and precursor forms (more likely in the endoplasmic reticulum and Golgi apparatus).

• Pulse-chase experiments: Combine antibody detection with pulse-chase labeling to track the conversion of precursor to mature forms over time.

• Prodomain cleavage analysis: Some variants at conserved positions within the prodomain may influence prodomain cleavage . Comparing wild-type and variant DSC2 can provide insights into processing mechanisms.

What approaches can resolve contradictory results when studying DSC2 protein interactions using different antibodies?

When faced with contradictory results from different DSC2 antibodies in protein interaction studies, consider these resolution approaches:

• Epitope mapping: Determine which specific regions of DSC2 each antibody recognizes. Antibodies targeting different domains (e.g., extracellular vs. cytoplasmic) may yield different results if interactions are domain-specific or if binding of the antibody disrupts particular interactions.

• Steric hindrance assessment: Some antibodies may sterically hinder protein-protein interactions, particularly if they bind near interaction interfaces. The N-terminal cadherin-like domains of DSC2 mediate homophilic interactions and heterophilic interactions with Desmoglein-2 ; antibodies targeting these regions might interfere with these interactions.

• Validation with multiple methods:

  • Complement co-immunoprecipitation with proximity ligation assays

  • Use recombinant tagged proteins to verify interactions independent of antibody binding sites

  • Employ in vitro binding assays with purified components

• Cross-reactivity analysis: Test for potential cross-reactivity with other desmocollins, as human DSC2 shares 54% and 64% amino acid sequence identity with Desmocollin-1 and Desmocollin-3, respectively .

• Conformation sensitivity: Some antibodies may be sensitive to calcium-dependent conformational changes in DSC2, as it is a calcium-dependent adhesion molecule . Standardize calcium conditions across experiments or specifically test different calcium concentrations.

How can I use DSC2 antibodies to investigate the role of the DSC2 prodomain in intracellular transport?

The DSC2 prodomain plays a critical role in intracellular transport to the plasma membrane . To investigate this process:

• Comparative localization studies: Use immunofluorescence with antibodies against different DSC2 domains to track the protein through the secretory pathway:

  • Co-stain with markers for the endoplasmic reticulum, Golgi apparatus, and plasma membrane

  • Compare wild-type DSC2 with prodomain deletion mutants or variants

• Site-directed mutagenesis experiments: Generate constructs with mutations at conserved prodomain positions that are hypothesized to influence intracellular localization due to different physicochemical properties . Analyze these with appropriate antibodies to determine effects on transport.

• Secretion assays: As described in the research literature, use secretion assays to compare wildtype DSC2 with variants like p.D30N and p.V79G . This approach can reveal whether prodomain mutations affect the secretory pathway.

• Prodomain cleavage analysis: Investigate whether variants at conserved positions within the prodomain influence prodomain cleavage . This can be accomplished using Western blot analysis with antibodies that distinguish between cleaved and uncleaved forms.

• Structure-function correlations: Analyze phylogenetically conserved positions in the prodomain, particularly those listed in genetic disease databases (e.g., ClinVar, HGMD, ARVC database) . This can help establish which regions of the prodomain are most critical for transport.

What factors affect DSC2 antibody performance in different applications?

Multiple factors can influence DSC2 antibody performance across applications:

• Fixation methods: For immunohistochemistry and immunofluorescence:

  • Perfusion-fixed frozen sections have been successfully used for DSC2 detection in mouse embryo tissues

  • Different fixatives (paraformaldehyde, methanol, acetone) may preserve different epitopes

• Epitope accessibility: The multi-domain structure of DSC2 means that some epitopes may be masked in certain contexts:

  • The extracellular domain contains five cadherin-like domains that may fold differently under various conditions

  • Protein-protein interactions at desmosomes might obscure certain epitopes

• Calcium sensitivity: As a calcium-dependent adhesion molecule, DSC2 conformation may be affected by calcium levels in buffers and fixatives .

• Species cross-reactivity: While human DSC2 shares 74%-79% amino acid sequence identity with bovine, mouse, and rat DSC2 , species-specific antibodies may be required for certain applications. For example, a synthetic peptide derived from human Desmocollin-2 shows only 66.7% homology to the rodent sequence .

• Antibody format: Consider whether native or denatured conditions are required for your application. Some epitopes may only be accessible in denatured conditions (Western blot) but not in native states (immunoprecipitation).

How can I optimize DSC2 antibody protocols for detection in difficult tissue types?

Optimizing DSC2 antibody protocols for challenging tissues requires systematic adjustments:

• Antigen retrieval optimization:

  • Test multiple retrieval methods (heat-induced in citrate buffer, EDTA, or enzymatic retrieval)

  • Adjust retrieval duration and temperature based on tissue type

  • For tissues with high lipid content (e.g., myocardium), consider lipid extraction steps

• Signal amplification strategies:

  • For low abundance detection, consider tyramide signal amplification

  • Use high-sensitivity detection systems like HRP-DAB for immunohistochemistry

  • For immunofluorescence, try secondary antibody amplification systems

• Background reduction techniques:

  • Optimize blocking with appropriate proteins (BSA, serum matched to secondary antibody host)

  • Include detergents (Triton X-100, Tween-20) at appropriate concentrations

  • Consider autofluorescence quenching for highly autofluorescent tissues

• Antibody concentration gradients:

  • Test dilution series to identify optimal concentration

  • For immunohistochemistry, concentrations around 5 μg/mL have been effective for some DSC2 antibodies

  • For immunofluorescence, 1:100 dilutions have been validated for some antibodies

• Incubation parameters:

  • Compare room temperature vs. 4°C incubation

  • Test various incubation durations (2 hours to overnight)

  • Consider specialized incubation chambers to prevent drying

What are effective strategies for dual or multiple labeling experiments involving DSC2 antibodies?

For successful multi-labeling experiments with DSC2 antibodies:

• Antibody compatibility planning:

  • Select primary antibodies from different host species to avoid cross-reactivity

  • If using multiple antibodies from the same species, consider direct conjugation or sequential labeling with monovalent Fab fragments

• Desmosomal protein co-localization:

  • DSC2 forms heterotypic interactions with Desmoglein-2 , making these proteins good candidates for co-localization studies

  • Include other desmosomal components (plakoglobin, desmoplakin) for comprehensive junction analysis

• Organelle co-labeling for trafficking studies:

  • Combine DSC2 antibodies with markers for ER, Golgi, and plasma membrane to track intracellular transport

  • Particularly useful when studying prodomain variants that affect subcellular localization

• Sequential labeling protocol:

  • For challenging combinations, implement sequential immunostaining with complete antibody elution between rounds

  • Document and subtract any residual signal from earlier rounds of staining

• Spectral considerations:

  • Choose fluorophores with minimal spectral overlap

  • Implement linear unmixing for fluorophores with partial overlap

  • Include proper single-stained controls for spectral compensation

How can I verify that DSC2 antibody detection correlates with functional DSC2 in my system?

Verifying that antibody-detected DSC2 is functionally active requires complementary approaches:

• Structure-function correlation:

  • Compare antibody staining patterns with functional assays of cell adhesion strength

  • Assess whether antibody-positive cells display normal desmosomal ultrastructure by electron microscopy

• Calcium-dependency tests:

  • As a calcium-dependent adhesion molecule , functional DSC2 should show calcium-dependent properties

  • Compare antibody staining under normal and calcium-depleted conditions

• Protein-protein interaction verification:

  • Functional DSC2 forms homophilic interactions and heterophilic interactions with Desmoglein-2

  • Use co-immunoprecipitation or proximity ligation assays to confirm these interactions in antibody-positive cells

• Trafficking and maturation assessment:

  • The DSC2 prodomain is essential for intracellular transport to the plasma membrane

  • Verify proper processing of the precursor to mature form using appropriate antibodies and subcellular localization studies

• Functional rescue experiments:

  • In cells with DSC2 knockdown or mutations, test whether reintroduction of wild-type DSC2 (detected by your antibody) restores normal desmosomal function and cell adhesion